Study Combining Suicide Gene Therapy With Chemoradiotherapy in the Treatment of Non-Metastatic Pancreatic Adenocarcinoma

Clinical trial NCT00415454 · TERMINATED

Trial details

NCT number: NCT00415454
Sponsor: Henry Ford Health System
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2006-11-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.